PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
-9.79%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$94.8M
AUM Growth
+$94.8M
(-16%)
Cap. Flow
-$1.4M
Cap. Flow
% of AUM
-1.48%
Top 10 Holdings %
Top 10 Hldgs %
44.47%
Holding
86
New
5
Increased
12
Reduced
38
Closed
4
Top Buys
| 1 |
Elutia
ELUT
|
$699K |
| 2 |
Butterfly Network
BFLY
|
$627K |
| 3 |
Crexendo
CXDO
|
$587K |
| 4 |
Sera Prognostics
SERA
|
$522K |
| 5 |
Codexis
CDXS
|
$351K |
Top Sells
| 1 |
Digi International
DGII
|
$1.37M |
| 2 |
OptimizeRx
OPRX
|
$539K |
| 3 |
Tactile Systems Technology
TCMD
|
$512K |
| 4 |
Inotiv
NOTV
|
$497K |
| 5 |
Airgain
AIRG
|
$421K |
Sector Composition
| 1 | Healthcare | 61.74% |
| 2 | Technology | 21.57% |
| 3 | Communication Services | 7.23% |
| 4 | Consumer Staples | 4.16% |
| 5 | Industrials | 3.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Eli Lilly
LLY
$657B
| $8.09M | 8.53% | 9,795 -115 | -1% | -$95K |
|
2
Natera
NTRA
$23.1B
| $7.05M | 7.43% | 49,825 -850 | -2% | -$120K |
|
3
Axogen
AXGN
$743M
| $4.69M | 4.95% | 253,534 -7,690 | -3% | -$142K |
|
4
Microsoft
MSFT
$3.77T
| $4.65M | 4.9% | 12,385 -25 | -0.2% | -$9.39K |
|
5
Idexx Laboratories
IDXX
$51.8B
| $4.07M | 4.3% | 9,700 | – | – |
|
6
Abbott
ABT
$231B
| $2.96M | 3.12% | 22,330 | – | – |
|
|
7
Elutia
ELUT
$96.7M
| $2.88M | 3.03% | 1,136,377 +276,300 | +32% | +$699K |
|
8
LeMaitre Vascular
LMAT
$2.16B
| $2.72M | 2.87% | 32,386 -250 | -0.8% | -$21K |
|
9
Veracyte
VCYT
$2.39B
| $2.57M | 2.71% | 86,550 -3,650 | -4% | -$108K |
|
10
Ooma
OOMA
$356M
| $2.5M | 2.64% | 191,179 +770 | +0.4% | +$10.1K |
|
11
Inuvo
INUV
$49.5M
| $2.49M | 2.63% | 7,015,317 -68,135 | -1% | -$24.2K |
|
12
Advanced Micro Devices
AMD
$264B
| $2.14M | 2.25% | 20,804 | – | – |
|
13
Cantaloupe
CTLP
$797M
| $1.85M | 1.95% | 234,600 -1,750 | -0.7% | -$13.8K |
|
14
Alphatec Holdings
ATEC
$2.35B
| $1.83M | 1.93% | 180,517 -1,050 | -0.6% | -$10.6K |
|
15
NeoGenomics
NEO
$1.13B
| $1.7M | 1.8% | 179,550 +600 | +0.3% | +$5.69K |
|
16
MDxHealth
MDXH
$176M
| $1.68M | 1.77% | 1,181,475 +198,000 | +20% | +$281K |
|
17
Magnite
MGNI
$3.7B
| $1.66M | 1.75% | 145,125 +1,300 | +0.9% | +$14.8K |
|
18
Exagen
XGN
$217M
| $1.52M | 1.6% | 422,971 -750 | -0.2% | -$2.69K |
|
19
Usio Inc
USIO
$39.2M
| $1.45M | 1.53% | 995,693 | – | – |
|
20
Backblaze
BLZE
$471M
| $1.38M | 1.45% | 285,525 +300 | +0.1% | +$1.45K |
|
21
AbbVie
ABBV
$372B
| $1.31M | 1.38% | 6,230 -78 | -1% | -$16.3K |
|
22
Vericel Corp
VCEL
$1.83B
| $1.19M | 1.25% | 26,600 -1,050 | -4% | -$46.9K |
|
23
Gilead Sciences
GILD
$140B
| $1.16M | 1.22% | 10,333 -500 | -5% | -$56K |
|
24
TELA Bio
TELA
$70.5M
| $1.11M | 1.17% | 910,615 +2,750 | +0.3% | +$3.36K |
|
25
LifeVantage
LFVN
$165M
| $1.1M | 1.16% | 75,508 -400 | -0.5% | -$5.83K |
|